Kurm Pharma ApS: Financial statements 2020
CVR: 39181274
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Kurm Pharma ApS (CVR 39181274) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 947,022 and a net result of DKK 704,980 compared with DKK 506,343 the year before. That is an increase of 42% compared with the year before. Equity in the 2020 report amounted to DKK 969,081. The solvency ratio was 22.6%.
- Gross Profit
- DKK 947,022
- Profit/Loss
- DKK 704,980
- Equity
- DKK 969,081
- Total Assets
- DKK 4,285,826
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 947 t. | 705 t. | 969 t. | - |
| 2019 | - | 667 t. | 506 t. | 904 t. | - |
| 2018 | - | 494 t. | 348 t. | 398 t. | - |
Official annual report
How creditworthy is Kurm Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of June 17, 2020, Johannes Gjelstrup has left the board of directors of Kurm Pharma ApS.
Kurm Pharma ApS has published its annual report for 2019. Gross profit came to DKK 666,835, and the net result was DKK 506,343.
About Kurm Pharma ApS
Kurm Pharma ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 2017. The company is registered under the industry Fremstilling af parfume, hårshampoo, tandpasta mv.. The management consists of Jacob Gjelstrup and Jesper Gjelstrup. The board consists of Steen Nordstrøm (chair), Allan Christensen, Jacob Gjelstrup and Jesper Gjelstrup. The company is owned by Fitzrovia ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -2,598,150 and a net result of DKK -1,978,646 compared with DKK 602,189 the year before. Equity in the 2025 report amounted to DKK 1,813,033.